Published in J Clin Microbiol on March 01, 1988
Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev (1997) 4.70
Evaluation of Statens Serum Institut enteric medium for detection of enteric pathogens. J Clin Microbiol (1999) 1.45
Yersinia enterocolitica: a frequent seasonal stool isolate from children at an urban hospital in the southeast United States. J Clin Microbiol (1991) 1.01
Contemporary testing for enteric pathogens: the potential for cost, time, and health care savings. J Clin Microbiol (1996) 0.92
Routine culturing of stool specimens for Yersinia enterocolitica. J Clin Microbiol (1988) 0.81
Development of a loop-mediated isothermal amplification assay for rapid detection of Yersinia enterocolitica via targeting a conserved locus. Iran J Microbiol (2015) 0.77
Current evidence for human yersiniosis in Ireland. Eur J Clin Microbiol Infect Dis (2012) 0.76
Synthesis of a selective agar medium for Yersinia enterocolitica. Can J Microbiol (1979) 3.31
Yersinia enterocolitica gastroenteritis: a prospective study of clinical, bacteriologic, and epidemiologic features. J Pediatr (1980) 2.73
Efficacy of cold enrichment techniques for recovery of Yersinia enterocolitica from human stools. J Clin Microbiol (1979) 2.13
Yersinia enterocolitica in adults with gastrointestinal disturbances: need for cold enrichment. J Clin Microbiol (1980) 1.82
Comparative study of selective media for recovery of Yersinia enterocolitica. J Clin Microbiol (1982) 1.28
Rapid isolation of Yersinia spp. from feces. J Clin Microbiol (1982) 1.24
Medium for isolation of Yersinia enterocolitica. J Clin Microbiol (1979) 1.17
Growth of Aeromonas spp. on cefsulodin-Irgasan-novobiocin agar selective for Yersinia enterocolitica. J Clin Microbiol (1985) 1.10
Evaluation of a pectin agar medium for isolation of Yersinia enterocolitica within 48 hours. Am J Clin Pathol (1979) 1.07
Lack of efficacy of alkali treatment for isolation of Yersinia enterocolitica from feces. J Clin Microbiol (1983) 0.92
Differential and selective medium for isolation of Yersinia enterocolitica from stools. J Clin Microbiol (1982) 0.86
Yersinia enterocolitica in Kansas. Attempted recovery from 1,212 patients. Am J Clin Pathol (1982) 0.85
Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet (2001) 5.90
Species identities of enterococci isolated from clinical specimens. J Clin Microbiol (1990) 4.54
Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp. Antimicrob Agents Chemother (2004) 3.82
In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria. Antimicrob Agents Chemother (1993) 3.80
Phylogenetic analysis of some Aerococcus-like organisms from clinical sources: description of Helcococcus kunzii gen. nov., sp. nov. Int J Syst Bacteriol (1993) 3.16
Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob Agents Chemother (1991) 3.00
Automated identification of gram-positive bacteria. J Clin Microbiol (1982) 2.94
Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18. Antimicrob Agents Chemother (2000) 2.80
Development of a standardized screening method for detection of vancomycin-resistant enterococci. J Clin Microbiol (1994) 2.77
Vancomycin-resistant gram-positive bacteria isolated from human sources. J Clin Microbiol (1988) 2.71
Bone-anchored hearing aids for people with bilateral hearing impairment: a systematic review. Clin Otolaryngol (2011) 2.58
Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci. Antimicrob Agents Chemother (1999) 2.49
Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases. J Clin Microbiol (1994) 2.47
Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae. J Clin Microbiol (1994) 2.44
Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates. J Clin Microbiol (1989) 2.43
In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms. Antimicrob Agents Chemother (1993) 2.29
Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother (1996) 2.22
Bioterrorism: implications for the clinical microbiologist. Clin Microbiol Rev (2001) 2.19
Helcococcus, a new genus of catalase-negative, gram-positive cocci isolated from clinical specimens. J Clin Microbiol (1995) 2.15
Use of the Rapid STREP system for identification of viridans streptococcal species. J Clin Microbiol (1983) 2.02
Identification of viridans streptococci isolated from clinical specimens. J Clin Microbiol (1982) 1.98
Autopsy findings in the acquired immune deficiency syndrome. JAMA (1984) 1.91
Systematic review of the psychological consequences of false-positive screening mammograms. Health Technol Assess (2013) 1.81
Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation. Health Technol Assess (2010) 1.80
New vancomycin disk diffusion breakpoints for enterococci. The National Committee for Clinical Laboratory Standards Working Group on Enterococci. J Clin Microbiol (1992) 1.79
Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test. J Clin Microbiol (1994) 1.78
Craniopharyngiomas in children. Long-term effects of conservative surgical procedures combined with radiation therapy. J Neurosurg (1990) 1.76
Multicenter evaluation of the use of Haemophilus test medium for broth microdilution antimicrobial susceptibility testing of Streptococcus pneumoniae and development of quality control limits. J Clin Microbiol (1992) 1.76
Comparison of Vibrio cholerae O139 with V. cholerae O1 classical and El Tor biotypes. Infect Immun (1994) 1.76
The role of the LFA-1/ICAM-1 interaction in human leukocyte homing and adhesion. Immunol Rev (1989) 1.75
Multiply resistant viridans streptococci: susceptibility to beta-lactam antibiotics and comparison of penicillin-binding protein patterns. Antimicrob Agents Chemother (1983) 1.74
Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent. Antimicrob Agents Chemother (1990) 1.71
Population-based nutritional risk survey of pensioners in Yerevan, Armenia. Am J Prev Med (1994) 1.70
New cause for false-positive results with the cryptococcal antigen test by latex agglutination. J Clin Microbiol (1985) 1.70
"Streptococcus milleri" strains displaying a gliding type of motility. Int J Syst Bacteriol (1995) 1.70
Occurrence of Streptococcus milleri among beta-hemolytic streptococci isolated from clinical specimens. J Clin Microbiol (1985) 1.64
Identification of Streptococcus bovis and Streptococcus salivarius in clinical laboratories. J Clin Microbiol (1984) 1.60
Ran-binding protein 3 is a cofactor for Crm1-mediated nuclear protein export. J Cell Biol (2001) 1.55
Cerebral hemicorticectomy for epilepsy. J Neurosurg (1992) 1.51
Colonization of skin by Helcococcus kunzii. J Clin Microbiol (1997) 1.51
Identification of "Streptococcus milleri" group isolates to the species level with a commercially available rapid test system. J Clin Microbiol (1995) 1.48
Comparison of fecal lactoferrin latex agglutination assay and methylene blue microscopy for detection of fecal leukocytes in Clostridium difficile-associated disease. J Clin Microbiol (1994) 1.47
Congenital hydrocephalus due to villous hypertrophy of the telencephalic choroid plexuses. Case report. J Neurosurg (1983) 1.43
Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness. Br J Cancer (2009) 1.43
The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review. Health Technol Assess (2011) 1.42
The intracranial pressure in infants. J Neurosurg (1980) 1.37
Frozen musculoskeletal allografts. A study of the clinical incidence and causes of infection associated with their use. J Bone Joint Surg Am (1990) 1.37
Catheter-associated infection with a vancomycin-resistant gram-positive coccus of the Leuconostoc sp. Pediatr Infect Dis J (1988) 1.36
Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties. Br J Pharmacol (1997) 1.35
Comparison of Enterococcus raffinosus with Enterococcus avium on the basis of penicillin susceptibility, penicillin-binding protein analysis, and high-level aminoglycoside resistance. Antimicrob Agents Chemother (1991) 1.35
Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother (2000) 1.34
In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms. Antimicrob Agents Chemother (1993) 1.33
Cytomegalovirus antigenemia: clinical correlations in transplant recipients and in persons with AIDS. J Clin Microbiol (1993) 1.33
Accurate automated identification of selected Enterobacteriaceae at four hours. J Clin Microbiol (1981) 1.32
Value of stool cultures. Lancet (1980) 1.26
Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci. J Clin Microbiol (1995) 1.25
Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents. Eur J Clin Microbiol Infect Dis (1989) 1.23
Infectious crystalline keratopathy. Role of nutritionally variant streptococci and other bacterial factors. Ophthalmology (1991) 1.23
Susceptibilities of Legionella spp. to newer antimicrobials in vitro. Antimicrob Agents Chemother (1998) 1.22
Evaluation of a cerebral oximeter as a monitor of cerebral ischemia during carotid endarterectomy. Anesthesiology (2000) 1.21
Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin. Eur J Clin Microbiol Infect Dis (1993) 1.21
RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagn Microbiol Infect Dis (1993) 1.20
Report of cases of and taxonomic considerations for large-colony-forming Lancefield group C streptococcal bacteremia. J Clin Microbiol (1995) 1.20
Comparative in vitro activity of SM7338, a new carbapenem antimicrobial agent. Antimicrob Agents Chemother (1989) 1.19
High prevalence of glycopeptide resistance genes vanB, vanD, and vanG not associated with enterococci in human fecal flora. Antimicrob Agents Chemother (2005) 1.19
Detection of enterococcal high-level aminoglycoside resistance with MicroScan freeze-dried panels containing newly modified medium and Vitek Gram-Positive Susceptibility cards. J Clin Microbiol (1991) 1.19
In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria. Antimicrob Agents Chemother (1989) 1.16
Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci. National Committee for Clinical Laboratory Standards Study Group on Enterococci. J Clin Microbiol (1995) 1.15
Cefuroxime screening test for pneumococci. J Clin Microbiol (1993) 1.14
Simple microbiologic detection of Campylobacter pylori. J Clin Microbiol (1988) 1.13
Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy. Am J Med (1990) 1.13
Gene transcription and chromosome replication in Escherichia coli. J Bacteriol (1997) 1.12
Distribution and incidence of viridans streptococcal species in routine clinical specimens. Am J Clin Pathol (1983) 1.11
Presumptive identification of "Streptococcus milleri" in 5 h. J Clin Microbiol (1986) 1.10
Identification of Enterobacteriaceae by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using the VITEK MS system. Eur J Clin Microbiol Infect Dis (2013) 1.09
Arsenic exposure, smoking, and respiratory cancer in copper smelter workers. Arch Environ Health (1983) 1.09
Residual shunt infection in a program aimed at its prevention. Z Kinderchir Grenzgeb (1979) 1.09
Ventricular perfusion in cats with kaolin-induced hydrocephalus. J Neurosurg (1974) 1.08
Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strain. J Clin Microbiol (1992) 1.07
Evaluation of two single-plate incubation systems and the anaerobic chamber for the cultivation of anaerobic bacteria. J Clin Microbiol (1990) 1.07
Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli. Eur J Clin Microbiol Infect Dis (2013) 1.07
Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation. Health Technol Assess (2010) 1.06
The first year of hyperinflation in the former Soviet Union: nutritional deprivation among elderly pensioners, 1992. Am J Public Health (1996) 1.05
Comparison of four methods in the diagnosis of Clostridium difficile disease. Eur J Clin Microbiol Infect Dis (1993) 1.05
Isolation and characterization of a novel receptor-type protein tyrosine kinase (hek) from a human pre-B cell line. J Biol Chem (1992) 1.05
A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit. Atherosclerosis (1998) 1.04
Occupational risk for primary cytomegalovirus infection among pediatric health-care workers. N Engl J Med (1983) 1.04
Implication of pneumolysin as a virulence factor in Streptococcus pneumoniae endophthalmitis. Retina (1997) 1.03
The permeation of several materials into the fluids of the rabbit's brain. J Physiol (1971) 1.02
Time to full publication of studies of anti-cancer medicines for breast cancer and the potential for publication bias: a short systematic review. Health Technol Assess (2008) 1.02
Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830). Diagn Microbiol Infect Dis (1990) 1.02